[Double radio-active labelling for the simultaneous study of autologous and homologous human platelets' life span (author's transl)].
In cases of thrombopenia of obscure origin, labelling human platelets in plasma medium with both radio-active indium and chromium makes it possible to study simultaneously the life span of infused autologous (111In) and homologous (51Cr) platelets. Examples are given where this method revealed a corpuscular abnormality of platelet kinetics.
D000818:Animals; D001792:Blood Platelets / Q000166:cytology*; D002470:Cell Survival; D002860:Chromium Radioisotopes; D006801:Humans; D007204:Indium; D007700:Kinetics; D011696:Purpura, Thrombocytopenic / Q000097:blood; D011868:Radioisotopes; D013921:Thrombocytopenia / Q000097:blood / Q000151:congenital / Q000235:genetics
D002860:Chromium Radioisotopes; D011868:Radioisotopes; D007204:Indium
Double marquage des plaquettes par 51Cr et 111In. Application à l'étude simultanée de la durée de vie des plaquettes autologues et homologues.